Cargando…
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children
Although children have been largely spared from coronavirus disease 2019 (COVID-19), the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) with increased transmissibility, combined with fluctuating mask mandates and school re-openings, have led to in...
Autores principales: | Bartsch, Yannic C, St Denis, Kerri J, Kaplonek, Paulina, Kang, Jaewon, Lam, Evan C, Burns, Madeleine D, Farkas, Eva J, Davis, Jameson P, Boribong, Brittany P, Edlow, Andrea G, Fasano, Alessio, Shreffler, Wayne G, Zavadska, Dace, Johnson, Marina, Goldblatt, David, Balazs, Alejandro B, Yonker, Lael M, Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348753/ https://www.ncbi.nlm.nih.gov/pubmed/35881018 http://dx.doi.org/10.1126/scitranslmed.abn9237 |
Ejemplares similares
-
Comprehensive antibody profiling of mRNA vaccination in children
por: Bartsch, Yannic C, et al.
Publicado: (2022) -
Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Burns, Madeleine D., et al.
Publicado: (2023) -
Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
por: Burns, Madeleine D, et al.
Publicado: (2022) -
Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children
por: Burns, Madeleine D., et al.
Publicado: (2022) -
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
por: Bartsch, Yannic C., et al.
Publicado: (2022)